NG

Nguyen Anh Tu

  • CIK: 0002058704
  • EIN:
  • Business address:

Information

  • Mailing address
    C/O XERIS PHARMACEUTICALS, INC., 1375 W FULTON ST., SUITE 1300, CHICAGO, IL, 60607
  • Phone
    N/A
  • State location
    N/A
  • State of incorporation
    N/A
  • Fiscal year end
    N/A
  • SIC
    N/A
  • Filings
    N/A

About Nguyen Anh Tu

Nguyen Anh Tu (CIK: 0002058704) is an American company incorporated in the state of N/A. Head office is located at . Work in the industry N/A. Nguyen Anh Tu is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Nguyen Anh Tu

Filings Format Description Filed/Effective File/Film Number
3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001867096-25-000045 (34 Act) Size: 0 KB		 Mar-07-2025

001-40880

25720177

Recent 20 filings. View all Nguyen Anh Tu filings

Reviews

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Frequently Asked Questions

Tags:

  • Nguyen Anh Tu overview
  • Nguyen Anh Tu job
  • Nguyen Anh Tu stock
  • Nguyen Anh Tu ownership
  • Nguyen Anh Tu CEO
  • Nguyen Anh Tu documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Jindal Chetan
Update: Apr 01, 2025
Holland Stefanie M
Update: Apr 01, 2025
Hanson Michael Donn
Update: Apr 01, 2025
Graham-Cumming John
Update: Apr 01, 2025
Golan Keren Gousman
Update: Apr 01, 2025
Globokar Brian R.
Update: Apr 01, 2025

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3053 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4493 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3673 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2703 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3511 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2733 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1063 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1634 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2943 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by